Title: Cancer Gene Therapy Market to grow at 20.7% CAGR from 2016 to 2024
1Global Cancer Gene Therapy Market share to grow
at 20.7 CAGR from 2016 to 2024 Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2Key Insights from Cancer Gene Therapy Market
- Global Market Insights, Inc., says Cancer gene
therapy industry revenue, which was assessed at
USD 805.5 million in 2015, is projected to hit
USD 4.3 billion by 2024. - A significant rise in the number of cancer
incidences has led to the deployment of genome
technologies, which will spur Cancer Gene Therapy
Market size. - Heavy funding by the government for cancer
research programs and beneficial schemes favoring
cancer screening programs are expected to produce
lucrative avenues for cancer gene therapy market. - Considering the regional trends, cancer gene
therapy industry in China, which accounted for
35 of Asia Pacific cancer gene therapy market
share in 2015, is projected to record a CAGR of
21 over the next few years, having collected a
revenue of USD 99.6 million in 2015. - Cancer gene therapy market in Japan, worth USD
78.2 million in 2015, is projected to expand at a
CAGR of 20.9 over the period from 2016 to 2024.
3Continued...
- UK cancer gene therapy industry, which was
assessed at USD 92 million in 2015, is set to
grow at an annual rate of 20.8 over the coming
seven years, subject to high frequency of cancer
among the nations population along with the
acceptance of modern treatment methodologies. - U.S. cancer gene therapy industry, which
contributed more than 95 of North America cancer
gene therapy market revenue in 2015, is projected
to grow at a rate of 20.9 over the coming seven
years. - Cancer gene therapies comprise gene transfer,
oncolytic virotherapy, and gene induced
immunotherapy. - NewLink Genetics Corporation, ZIOPHARM Oncology
Incorporation, Shenzhen Sibiono GeneTech Company
Limited, Genelux Corporation, Gradalis
Incorporation, Altor Bioscience Corporation,
Shanghai Sunway Biotech Company Limited, Amgenen
Incorporation, MultiVir Incorporation, Aduro
Biotech Incorporation, OncoGeneX Pharmaceuticals
Company, GlobeImmune Incorporation, MolMed
S.p.A., and BioCancell Therapeutic Incorporation
are the few of the established players of cancer
gene therapy industry.
4U.S. Cancer Gene Therapy Market size, by type,
2012 - 2024 (USD Million)
5 Browse Full Market Research Report On Cancer
Gene Therapy Market _at_ http//bit.ly/2cXsFFD
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/763 https//www.gminsights.com/request-sa
mple/detail/49
6Table of Content
Chapter 1. Methodology and Scope 1.1. Research
Methodology 1.1.1. Initial data
exploration 1.1.2. Statistical modeling and
forecast 1.1.3. Industry insights and
validation 1.1.4. Research scope assumptions
1.2. Data Sources Chapter 2. Executive
Summary 2.1. Cancer genetics industry 3600
synopsis, 2012 - 2024 2.1.1. Business
trends 2.1.2. Regional trends 2.1.3.
Application trends Chapter 3. Cancer Gene
Therapy Industry Insights 3.1. Industry
segmentation
7Table of Content
3.2. IIndustry Size and forecast, 2012 -
2024 3.3. Industry Impact forces 3.3.1.
Growth drivers 3.3.1.1. Technological
advancements 3.3.1.2. Increased adoption of
nanotechnology 3.3.1.3. Favorable
government regulations 3.3.2. Industry
pitfalls challenges 3.3.2.1. High cost of
cancer genetherapy 3.4. Growth potential
analysis 3.5. Porters analysis 3.6. Key
opportunities prioritized, 2015 3.7. PESTEL
analysis 3.8. Regulatory Landscape 3.8.1.
U.S. 3.8.2. EU 3.8.3. China
8Table of Content
3.9. Scientific and Ethical issues in Gene
Therapy 3.10. Competitive landscape, 2015 3.11.
Pipeline Analysis by cancer type 3.11.1.
Head and Neck Cancer Pipeline Analysis 3.11.2.
Breast Cancer Pipeline Analysis 3.11.3.
Gastro Intestinal Cancer Pipeline
Analysis 3.11.4. Gentiourinary Cancer
Pipeline Analysis 3.11.5. Gynecological
Cancer Pipeline Analysis 3.11.6.
Haemotological Cancer Pipeline Analysis 3.11.7.
Neurologic Cancer Pipeline Analysis 3.11.8.
Respiratory Cancer Pipeline Analysis 3.11.9.
Skin Cancer Pipeline Analysis
9 Stay In Touch Website www.gminsights.com Soci
al Media